Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-28

Clinical Trial Update: Carbidopa for the Treatment of Nausea and Vomiting in Familial Dysautonomia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating carbidopa for nausea and vomiting in familial dysautonomia has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbidopa (Carbidopa)

Snippet

Sponsor: NYU Langone Health | Conditions: Familial Dysautonomia | Phase 3 | Status: COMPLETED | Results posted: 2016-03-28